NeuroDerm Ltd. Ordinary Shares
NDRM
NDRM was delisted on the 17th of October, 2017.
56 hedge funds and large institutions have $297M invested in NeuroDerm Ltd. Ordinary Shares in 2016 Q4 according to their latest regulatory filings, with 15 funds opening new positions, 26 increasing their positions, 13 reducing their positions, and 9 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
100% more repeat investments, than reductions
Existing positions increased: 26 | Existing positions reduced: 13
73% more capital invested
Capital invested by funds: $171M → $297M (+$126M)
67% more first-time investments, than exits
New positions opened: 15 | Existing positions closed: 9
12% more funds holding
Funds holding: 50 → 56 (+6)
100% less call options, than puts
Call options by funds: $3K | Put options by funds: $2.77M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SCM
Scopia Capital Management
New York
|
+$18.7M |
| 2 |
RG
Redmile Group
San Francisco,
California
|
+$14.1M |
| 3 |
Franklin Resources
San Mateo,
California
|
+$9.35M |
| 4 |
Millennium Management
New York
|
+$7.86M |
| 5 |
ACA
Avoro Capital Advisors
New York
|
+$6.92M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BFA
BlackRock Fund Advisors
San Francisco,
California
|
-$5.27M |
| 2 |
PA
Perceptive Advisors
New York
|
-$3.86M |
| 3 |
NC
Nexthera Capital
New York
|
-$2.42M |
| 4 |
SFM
Sphera Funds Management
Tel Aviv,
Israel
|
-$1.45M |
| 5 |
FHAM
Folger Hill Asset Management
New York
|
-$1.22M |
NDRM Hedge Fund Activity: Q4 2016 in Review
56 of the 4,000 institutional investors tracked by Wall St. Rank reported a position in NeuroDerm Ltd. Ordinary Shares (NDRM) for Q4 2016, worth a combined $297M — up 73% from $171M a quarter earlier.
Buyers outnumbered sellers: 15 funds opened new NDRM positions and 9 closed out — a net gain of 6 holders — while 26 added to existing stakes and 13 trimmed.
The largest buyer was Scopia Capital Management, adding an estimated $18.7M. The largest seller was BlackRock Fund Advisors, cutting an estimated $5.27M.
- 56 institutional investors held NeuroDerm Ltd. Ordinary Shares (NDRM) as of Q4 2016, up from 50 in Q3 2016.
- Funds reported $297M of NeuroDerm Ltd. Ordinary Shares stock for Q4 2016, up 73% quarter-over-quarter.
- 15 funds opened new NeuroDerm Ltd. Ordinary Shares positions in Q4 2016 and 9 closed out, a net change of +6 holders.
- The largest NeuroDerm Ltd. Ordinary Shares buyer in Q4 2016 was Scopia Capital Management, an estimated $18.7M added.
- The largest NeuroDerm Ltd. Ordinary Shares seller in Q4 2016 was BlackRock Fund Advisors, an estimated $5.27M sold.
Based on aggregated 13F filings for Q4 2016.